Constitutional Opinion No. 2026-0669
Case Information
- Content Scored
- H.R. 4818 (118th) — Treat and Reduce Obesity Act of 2023 (Medicare obesity-treatment / Part D drug coverage expansion)
- Source
- U.S. Congress (govinfo.gov)
- Author
- Reps. Wenstrup, Ruiz, Miller-Meeks, Moore (WI)
- Publication Date
- 2023-07-20
- Content Type
- Legislation
- Opinion Issued
- 2026-07-19
- AFCS Version
- 1.0
Holding
H.R. 4818 amends Medicare to expand coverage of obesity treatment: Section 3 authorizes intensive behavioral therapy from a broadened set of providers on physician referral; Section 4 permits Part D plans to cover drugs used for the treatment of obesity or weight-loss management for overweight individuals with comorbidities; Section 5 adds an HHS reporting requirement. The Court evaluates this as operative statutory text scored for the policy it enacts, triggering the v1.2 Legal/Normative Text Weighting (85/15) so the text's authenticity (Tier 2 = 88) does not buoy a substantively-assessed provision. Under the Standard's limited-government commitments, the bill is a federal entitlement expansion — enlarging Medicare spending (anti-obesity drugs are costly) and federal healthcare authority — and is misaligned on Honest Money (X) and Federalism (XII), mildly on Property and Enterprise (IX). No AFCS Article rewards expanded healthcare coverage (the former Healthcare & Medical Freedom article is retired). Tier 1 = 37; under 85/15 the substance governs and the result is 45 — Mixed. New spending is not a new tax, so no Automatic Fail. Its narrow, permissive, within-Medicare design keeps it out of the lower bands. (Default 70/30 would have returned 52.)
It is the judgment of this Court that Opinion No. 2026-0669 is hereby entered into the record, in accordance with the America First Constitutional Standard. The score stands. The reasoning is published. The record is public.